Pages that link to "Q34248321"

The following pages link to Specific chemical dissociation of fibrillar and non-fibrillar components of amyloid deposits (Q34248321):

Displaying 25 items.

• Molecular chaperone properties of serum amyloid P component (Q22254102) (← links)
• Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis (Q24562844) (← links)
• The structures of crystalline complexes of human serum amyloid P component with its carbohydrate ligand, the cyclic pyruvate acetal of galactose (Q27639384) (← links)
• Structure of pentameric human serum amyloid P component (Q27731194) (← links)
• Crystal structure of a decameric complex of human serum amyloid P component with bound dAMP (Q27740302) (← links)
• Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis (Q28217930) (← links)
• Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene (Q28246156) (← links)
• The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo (Q34188358) (← links)
• Lectin-carbohydrate interaction in the immune system (Q34414914) (← links)
• Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure (Q35501399) (← links)
• Amyloid accomplices and enforcers (Q35970547) (← links)
• Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivo (Q36635583) (← links)
• Microvascular pathology and vascular basement membrane components in Alzheimer's disease (Q40611391) (← links)
• Free radical involvement in aging. Pathophysiology and therapeutic implications (Q40886414) (← links)
• Vascular basement membrane components and the lesions of Alzheimer's disease: light and electron microscopic analyses (Q46352808) (← links)
• Amyloid P component. A critical review (Q56595320) (← links)
• Complement activation by the amyloid proteins Aβ peptide and β2-microglobulin (Q58251610) (← links)
• Small drugs lead the attack (Q59006214) (← links)
• The Pentraxins 1975-2018: Serendipity, Diagnostics and Drugs (Q59127894) (← links)
• Amyloid elastosis: Analysis of the role of amyloid P component (Q67653518) (← links)
• Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosis (Q68298681) (← links)
• Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits (Q68986442) (← links)
• Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component (Q69919964) (← links)
• Comparative analyses of pentraxins: implications for protomer assembly and ligand binding (Q72609807) (← links)
• [Mechanisms of amyloidosis and the proteins involved] (Q73470676) (← links)